Pot stocks vs Medipharm Labs/pharma applications and upside:Let's analyze the political environment in North America and apply that to the global market. Which segment within the cannabis industry has the most upside potential in North America and globally, the recreational market or the pharmaceutical market segment for cannabis?
For example, Subo over in the Asian region of the world or Mohammed in the Middle East region of the world may not enjoy or even give any thought to enjoying cannabis at the recreational level even if completely legal but on health related matters, a pharmaceutical prescriptiondrug with a cannabinoid API to treat their health issue is no longer so much a personal choice of recreation but a personal choice regarding one's health.
That's the real upside segment within the wide and varied cannabis domain.
Just reminding, don't get caught in a sucker's rally in the recreational segment because that could still be years away and maybe never in some countries.